Terry Fox funding supports two research projects

Guest Contributor
October 24, 2012

The Terry Fox Research Institute (TFRI) is investing $13.4 million in two established research teams focused on oncolytic viruses and leukemia. The funding flows through TFRI's New Frontiers Program Project Grants, the Terry Fox Foundation's flagship program. An Ottawa-based team led by Dr John Bell, a senior scientist at the Ottawa Hospital Research Institute, will receive $7.5 million to fund its trans-Canada network examining the use of oncolytic viruses as biotherapeutics to treat cancer. The funding includes $500,000 from the Canadian Institutes of Health Research, which assisted TFRI in managing the selection and review of the successful programs. A Vancouver-based team at the BC Cancer Agency will receive $5.9 million to develop new ways of treating aggressive forms of leukemia by creating and using laboratory-built models that mimic human acute leukemia....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.